Interest of the BLAST paradigm and salivary markers for the evaluation of sleepiness in drivers.

attention biomarkers oxalate saliva sleep vigilance α-amylase

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2022
Historique:
received: 11 07 2022
accepted: 22 08 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 27 9 2022
Statut: epublish

Résumé

Sleepiness is associated with decreased cognitive abilities and remains one of the main causes of fatal road accidents. The tools currently available to assess sleepiness, such as questionnaires, are subject to intra- and inter-individual variability, while multiple sleep latency tests are only feasible in few sleep laboratories. The main objective of this study was to explore new potential markers (neurocognitive, biological) to objectively assess sleepiness in drivers. A total of 186 drivers (median age 44 years, range 20-74 years, 73% men, 14% obese) were included during a break at a highway service area, in the morning, while on the road for vacation. Questionnaires on sleepiness and sleep characteristics (habitual and on the night before travel), the Bron-Lyon Attention Stability Test (BLAST), and two salivary samples (α-amylase and oxalate) were collected. Associations between measures of sleepiness [Epworth Sleepiness Scale (ESS), and Stanford Sleepiness Scale (SSS)], sleep characteristics, neurocognitive, and biological markers were tested using regression models adjusted for confounding factors. The night before travel, 83% of the drivers reduced their sleep time and 30% slept 5 h or less. The higher the number of miles to be traveled, the higher the decrease, and the shorter the sleep time. The night before travel, 18 and 24% of the drivers complained of poor sleep quality and difficulty falling asleep. The sleep characteristics on the night before travel were associated with the habitual sleep characteristics. At the time of the test, 47% of the drivers scored pathologically on the SSS. Poor sleep quality and difficulty falling asleep the night before travel were associated with increased sleepiness as assessed by the SSS and decreased attentional ability as assessed by the BLAST. No association between salivary markers and acute sleepiness was observed. The sleep characteristics of the night before travel were associated with sleepiness and attentional performance. The SSS and the BLAST could be used by individual drivers in a self-evaluation context. Biological markers showed a high variability and limited association with sleep parameters across subjects, emphasizing the need for within-subject designs to assess their usefulness.

Identifiants

pubmed: 36161153
doi: 10.3389/fnins.2022.991528
pmc: PMC9490274
doi:

Types de publication

Journal Article

Langues

eng

Pagination

991528

Informations de copyright

Copyright © 2022 Thieux, Guyon, Herbillon, Merle, Lachaux, Plancoulaine, Seugnet and Franco.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Cancer Res. 2007 Nov 1;13(21):6359-68
pubmed: 17975148
Accid Anal Prev. 2019 May;126:160-172
pubmed: 29402402
J Clin Biochem Nutr. 2017 Nov;61(3):210-216
pubmed: 29203963
Nat Commun. 2021 Jun 29;12(1):3657
pubmed: 34188023
NMR Biomed. 2009 Jul;22(6):577-84
pubmed: 19259987
Clin Chim Acta. 1986 Jan 15;154(1):49-58
pubmed: 3943224
Dev Psychobiol. 2014 Sep;56(6):1300-15
pubmed: 24604597
J Clin Sleep Med. 2020 Sep 15;16(9):1507-1515
pubmed: 32406372
Psychoneuroendocrinology. 2009 May;34(4):469-85
pubmed: 19155141
Cortex. 2020 Oct;131:195-209
pubmed: 32906014
Epilepsy Behav. 2019 Oct;99:106470
pubmed: 31430660
Psychophysiology. 1973 Jul;10(4):431-6
pubmed: 4719486
Ann N Y Acad Sci. 2008;1129:305-22
pubmed: 18591490
Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):19-24
pubmed: 27838094
Eur Respir J. 1996 Jan;9(1):117-24
pubmed: 8834344
Am J Med Sci. 2019 Jun;357(6):468-473
pubmed: 31126512
Clin Physiol. 1996 Jul;16(4):433-48
pubmed: 8842578
Sci Rep. 2019 Mar 14;9(1):4428
pubmed: 30872634
Rev Mal Respir. 2007 Mar;24(3 Pt 1):305-13
pubmed: 17417168
J Clin Endocrinol Metab. 2003 May;88(5):2087-95
pubmed: 12727959
Biol Psychol. 2008 Apr;78(1):20-8
pubmed: 18243483
Ann N Y Acad Sci. 2007 Mar;1098:122-44
pubmed: 17332070
Accid Anal Prev. 2013 Oct;59:618-22
pubmed: 23973762
J Sleep Res. 2000 Mar;9(1):5-11
pubmed: 10733683
Neuropsychologia. 2019 Nov;134:107151
pubmed: 31541659
Med Clin North Am. 2010 May;94(3):531-40
pubmed: 20451030
Psychoneuroendocrinology. 2007 May;32(4):392-401
pubmed: 17418498
J Clin Neurophysiol. 2006 Feb;23(1):39-49
pubmed: 16514350
Conserv Physiol. 2018 Feb 16;6(1):coy005
pubmed: 29479432
Brain Sci. 2022 Feb 07;12(2):
pubmed: 35203992
Chronobiol Int. 2004;21(6):991-1001
pubmed: 15646244
Nat Rev Neurosci. 2002 Mar;3(3):201-15
pubmed: 11994752
Physiol Behav. 2019 May 15;204:1-9
pubmed: 30731103
Nat Neurosci. 2006 Jul;9(7):971-8
pubmed: 16767087
Sleep. 2003 Mar 15;26(2):117-26
pubmed: 12683469
Psychophysiology. 2001 Sep;38(5):828-35
pubmed: 11577906
Int J Environ Res Public Health. 2016 Aug 18;13(8):
pubmed: 27548196
Brain Behav Immun. 2015 Jul;47:24-34
pubmed: 25640603
Ann Intern Med. 2006 Jun 6;144(11):785-91
pubmed: 16754920
Int J Environ Res Public Health. 2021 Sep 02;18(17):
pubmed: 34501877
Clocks Sleep. 2021 Apr 30;3(2):259-273
pubmed: 33946265
Cereb Cortex. 2012 Apr;22(4):962-70
pubmed: 21734253
J Clin Endocrinol Metab. 2014 Aug;99(8):2861-8
pubmed: 24823456
Chem Pharm Bull (Tokyo). 2017;65(11):1011-1019
pubmed: 29093287
Neuroimage. 2013 May 1;71:275-83
pubmed: 23376698
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19913-8
pubmed: 17167051
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2569-74
pubmed: 25675494
J Sleep Res. 2006 Sep;15(3):291-300
pubmed: 16911031
BMJ. 2002 May 11;324(7346):1125
pubmed: 12003884
Sleep. 2010 Jan;33(1):123-9
pubmed: 20120629
Physiol Behav. 2021 Oct 15;240:113549
pubmed: 34371023
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
Sleep Med. 2012 Aug;13(7):852-8
pubmed: 22705245
Front Neurosci. 2020 Jan 08;13:1366
pubmed: 31998056
Eur J Clin Chem Clin Biochem. 1994 Nov;32(11):821-5
pubmed: 7888477
Int J Psychophysiol. 2020 Dec;158:331-339
pubmed: 33130179
Front Neurosci. 2019 Sep 13;13:949
pubmed: 31572112
Sleep. 1981;4(1):83-91
pubmed: 7232973
Arch Ital Biol. 2001 Apr;139(3):253-67
pubmed: 11330205
J Clin Sleep Med. 2014 May 15;10(5):559-66
pubmed: 24812542
Soc Cogn Affect Neurosci. 2018 Mar 1;13(3):290-299
pubmed: 29432569
Psychoneuroendocrinology. 2016 Jun;68:100-10
pubmed: 26963376
Psychoneuroendocrinology. 2017 Apr;78:131-141
pubmed: 28196342
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Arch Intern Med. 1994 Oct 10;154(19):2219-24
pubmed: 7944843
Pharmacol Biochem Behav. 2013 Oct;111:128-35
pubmed: 24051231
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Sleep Med. 2015 Aug;16(8):994-8
pubmed: 26100444
PLoS One. 2013 Aug 15;8(8):e72576
pubmed: 23967320
PLoS One. 2010 Oct 13;5(10):e13352
pubmed: 20967220
Electroencephalogr Clin Neurophysiol. 1997 May;102(5):383-9
pubmed: 9191581
Presse Med. 2015 Oct;44(10):1022-8
pubmed: 26453286
Sleep. 2007 Dec;30(12):1808-13
pubmed: 18246990
Psychophysiology. 1997 Nov;34(6):721-5
pubmed: 9401427
J Pediatr Urol. 2017 Feb;13(1):41.e1-41.e8
pubmed: 27876406
Front Behav Neurosci. 2016 May 23;10:95
pubmed: 27242464

Auteurs

Marine Thieux (M)

Centre de Recherche en Neurosciences de Lyon (CRNL), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Centre de Référence Maladies Rares (CRMR) Narcolepsie-Hypersomnies Rares, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon (HCL), Lyon, France.

Aurore Guyon (A)

Centre de Référence Maladies Rares (CRMR) Narcolepsie-Hypersomnies Rares, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon (HCL), Lyon, France.

Vania Herbillon (V)

Centre de Recherche en Neurosciences de Lyon (CRNL), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Centre de Référence Maladies Rares (CRMR) Narcolepsie-Hypersomnies Rares, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon (HCL), Lyon, France.

Lydie Merle (L)

Centre de Recherche en Neurosciences de Lyon (CRNL), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.

Jean-Philippe Lachaux (JP)

Centre de Recherche en Neurosciences de Lyon (CRNL), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.

Sabine Plancoulaine (S)

CRESS, Inserm, INRAE, Université Paris Cité, Paris, France.

Laurent Seugnet (L)

Centre de Recherche en Neurosciences de Lyon (CRNL), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.

Patricia Franco (P)

Centre de Recherche en Neurosciences de Lyon (CRNL), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Centre de Référence Maladies Rares (CRMR) Narcolepsie-Hypersomnies Rares, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon (HCL), Lyon, France.

Classifications MeSH